Louisiana Gene Therapy/LCRC Revenue, Growth & Competitor Profile

DBA DEBORAH REEDER
DBA LOUISIANA GENE THERAPY

Company Profile & Annual Report for Louisiana Gene Therapy/LCRC

Access the complete profile.

Louisiana Gene Therapy/LCRC Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	1700 Tulane Ave 10th Fl New Orleans, LA 70112

Note: Revenues for privately held companies are statistical evaluations.


Louisiana Gene Therapy/LCRC's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Louisiana Gene Therapy/LCRC's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Louisiana Gene Therapy/LCRC is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Louisiana Gene Therapy/LCRC Annual Revenue and Growth Rate

Louisiana Gene Therapy/LCRC	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Louisiana Gene Therapy/LCRC's revenues are gauged from an analysis of company filings.

Louisiana Gene Therapy/LCRC's Income Statement (based on Industry Averages)

Louisiana Gene Therapy/LCRC P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Louisiana Gene Therapy/LCRC's Largest Competitors

A competitive analysis shows these companies are in the same general field as Louisiana Gene Therapy/LCRC, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Louisiana Gene Therapy/LCRC. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AXOSIM	New Orleans, LA	100
OBATALA SCIENCES	New Orleans, LA	44
LOUISIANA GENE THERAPY/LCRC	New Orleans, LA	40
RDA	New Orleans, LA	27
NONPROFIT KNOWLEDGE WORKS	New Orleans, LA	13
WATERBORNE	New Orleans, LA	9

Future Competition: Louisiana Gene Therapy/LCRC's Fastest Growing Competitors

These companies are in the same general field as Louisiana Gene Therapy/LCRC and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)